Entero Healthcare Subsidiary Pays GST Penalty Under Protest, Plans Refund Claim
NiveshIQ
NSE: ENTERO · Healthcare
Entero Healthcare Solutions Ltd.
₹1,815.40▲ ₹22.50 (+1.25%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ENTERO. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label, such as monitoring devices, nursing and rehabilitation products, and consumables; commercial solutions; and healthcare product distribution solutions, including imports, central warehousing, redistr
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,922 Cr +128.60% | ₹5,096 Cr +29.90% | ₹6,591 Cr +29.30% |
| EBITDA Margin | 2.88% | 3.36% | 4.33% |
| Net Profit | ₹39.00 Cr | ₹107.00 Cr +174.40% | ₹154.02 Cr +43.90% |
| EPS | ₹27.41 | ₹21.81 | ₹26.44 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Entero Healthcare subsidiary penalised ₹12.9 lakh for GST E-Invoice lapse
Entero Healthcare GST Penalty: Subsidiary ACE Cardiopathy Fined
🔒
+ 3 more stories about Entero Healthcare Solutions Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹1, 940 Cr, PAT ₹52 Cr, EPS ₹8.77, EBITDA margin 5.2%. Growth context: revenue QoQ +1.6%, PAT QoQ +85.8%. Street verdict: strong beat, revenue surprise +5.6%, PAT surprise +75.8%.
Recent corporate activity highlights product launches, approvals, and therapy-mix improvement and order wins, deal pipel...
FY26 (last completed FY): revenue ₹6, 591 Cr, PAT ₹154 Cr, EBITDA margin 4.3%, EPS ₹26.44. Year-on-year: revenue YoY +29...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ENTERO
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ENTERO alongside your other holdings
Unlock full ENTERO research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Entero Healthcare Solutions Ltd.?
NiveshIQ detects active intelligence signals for Entero Healthcare Solutions Ltd. (ENTERO) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Entero Healthcare Solutions Ltd.?
Entero Healthcare Solutions Ltd. operates in the Healthcare sector with a market capitalisation of ₹540,991.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.